Oral nanoparticle vaccine could protect against HIV

In a paper in Nature Medicine co-authored by researchers from delivery company Nanotherapeutics and the National Cancer Institute (NCI), oral pH-dependent microparticles delivered a nanoparticle vaccine to the large intestine and triggered immunity in mice, protecting them against rectal and vaginal viral challenge. A vaccine using this technology could be given orally and could potentially protect people against HIV and other infections. Press release | Abstract

Like what you're reading?
Click here to get more news delivered to your inbox every week>>

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…